Therapy With the Stable Gastric Pentadecapeptide BPC 157
Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ
"Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts." "Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care." "Such practices not only help prevent excess weight gain, but can also lead to numerous health benefits that go beyond weight control." Why patients quit Recent reports have disclosed that more older Americans are deciding to quit their GLP-1s for a variety of reasons
This is all done under local anesthesia, eliminating the need for sedation
10.1002/prot.22171 126 RudolphT
These megadoses often arent necessary, and in some cases could even be dangerous if they exceed the tolerable upper intake level